| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 12,249,000 | 14,499,000 | 14,814,000 | 15,667,000 | | Cost of Revenue | 9,107,000 | 10,557,000 | 10,664,000 | 11,359,000 | | | Gross Profit | 3,142,000 | 3,942,000 | 4,150,000 | 4,308,000 | | | Operating Expenses | | Research Development | 409,000 | 490,000 | 436,000 | 434,000 | | Selling General and Administrative | 1,483,000 | 1,649,000 | 1,665,000 | 1,775,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,250,000 | 1,803,000 | 2,049,000 | 2,099,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,250,000 | 1,803,000 | 2,049,000 | 2,099,000 | | Interest Expense | 175,000 | 171,000 | 177,000 | 176,000 | | Income Before Tax | 1,075,000 | 1,632,000 | 1,872,000 | 1,923,000 | | Income Tax Expense | 276,000 | 403,000 | 502,000 | 548,000 | | Minority Interest |
-
| (84,000) | (101,000) | (100,000) | | | | Net Income From Continuing Ops | 799,000 | 1,145,000 | 1,269,000 | 1,275,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 799,000 | 1,145,000 | 1,269,000 | 1,275,000 | | Preferred Stock And Other Adjustments | (77,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $722,000 | $1,145,000 | $1,269,000 | $1,275,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
